IP Library › Granted Patent US 8,728,462
Granted Patent B2
US 8,728,462 · App. 12/768,529 · Granted May 20, 2014

Antimicrobial compositions and related methods of use

Inventors: Niranjan Ramanlal Gandhi (River Hills, WI); Victoria Palmer Skebba (Cedarburg, WI); Gary A. Strobel (Bozeman, MT)
Assignee: Jeneil Biosurfactant Company, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,728,462
App. No.
12/768,529
Granted
May 20, 2014
Kind
B2
Abstract

Antimicrobial compositions comprising one or more compound components generally recognized as safe for human consumption, and related methods of use, such compositions and methods as can be employed in a wide range of agricultural, industrial, building, pharmaceutical and/or personal care products and applications.

Claims (48)

1. An antimicrobial composition comprising a naturally-derived C 2 -C 5 acid component; a naturally-derived C 2 -C 5 acid ester component; a naturally-derived C 3 -C 5 ketone component; and at least two naturally-derived C 2 -C 5 components isolatable from a volatile by-product of an isolated culture of Muscodor crispans grown on potato dextrose agar, providing said composition is absent naphthalene and azulene derivative compounds.

2. The composition of claim 1 wherein said acid component is selected from isobutyric acid, propanoic acid and combinations thereof.

3. The composition of claim 1 wherein said ester component is selected from esters of acetic acid, propanoic acid and isobutyric acid and combinations of said esters.

4. The composition of claim 1 comprising 8-10 said components isolatable from a volatile by-product of M. crispans.

5. The composition of claim 4 wherein each said component of said composition is isolatable from a volatile by-product of M. crispans.

6. The composition of claim 5 wherein each said component is a fermentation product, said fermentation selected from bacterial, yeast and fungal fermentation.

7. The composition of claim 6 where each said component of said composition is generally recognized as safe for human consumption under Chapter 21 of the United States Code of Federal Regulations.

8. The composition of claim 1 comprising a rhamnolipid component.

9. An antimicrobial composition comprising 8-10 components selected from naturally-derived C 2 -C 5 alcohols, naturally-derived C 3 -C 5 ketones, naturally-derived C 2 -C 5 aldehydes, naturally-derived C 2 -C 5 acids and naturally-derived C 2 -C 5 acid esters, each said component isolatable from an isolated culture of M. crispans grown on potato dextrose agar, each said component of said composition generally recognized as safe for human consumption under Chapter 21 of the United States Code of Federal Regulations.

10. The composition of claim 9 wherein one of said isolatable acid components is isobutyric acid.

11. The composition of claim 10 wherein propanoic acid is at least in part substituted for said isobutyric acid.

12. The composition of claim 9 wherein one of said isolatable ketone components is 2-butanone.

13. The composition of claim 12 wherein acetic acid, propanoic acid or a combination thereof is at least in part substituted for said butanone.

14. The composition of claim 9 wherein one of said isolatable alcohol components is ethanol.

15. The composition of claim 14 wherein acetic acid is at least in part substituted for said ethanol.

16. The composition of claim 9 comprising a rhamnolipid component.

17. The composition of claim 9 incorporated with an article of manufacture.

18. The composition of claim 17 wherein said article is selected from a human food product, an animal food product, a beverage product, a packaging product and a personal care product.

19. The composition of claim 9 applied to a plant substrate.

20. The composition of claim 19 wherein said substrate is selected from a seed, a plant surface component, a fruit and a vegetable.

21. The composition of claim 20 wherein said substrate is selected from pre-harvest fruits and vegetables and from post-harvest fruits and vegetables.

22. An article of manufacture comprising a composition of claim 1 .

23. The article of claim 22 selected from a human food product, an animal food product, a beverage product, a packaging product, personal care product, product processing equipment, a medical apparatus and a dental apparatus.

24. The article of claim 23 wherein said human food product is elected from meats and meat products.

25. The article of claim 23 wherein said animal food product is a pet food.

26. The article of claim 23 wherein said beverage product is a fruit drink.

27. The article of claim 23 wherein said packaging product is a film.

28. The article of claim 23 wherein said personal care product is a skin lotion.

29. The article of claim 23 wherein said processing equipment is equipment for processing human food.

30. The article of claim 23 wherein said apparatus is selected from medical and dental implements and medical and dental implants.

31. A composition of claim 1 , said composition applied to a plant substrate.

32. A composition of claim 31 wherein said substrate is selected from seeds for agricultural crops.

33. The composition of claim 31 wherein said substrate is selected from plant stems and foliage.

34. The composition of claim 31 wherein said substrate is selected from pre-harvest fruits, vegetables and nuts, and post-harvest fruits, vegetables and nuts.

35. The composition of claim 34 wherein said substrate is selected from citrus fruits, potatoes and peanuts.

36. A synthetic, non-naturally-derived antimicrobial composition comprising a C 2 -C 5 acid component; a C 2 -C 5 acid ester component; a C 3 -C 5 ketone component; and at least two C 2 -C 5 components isolatable from a volatile by-product of an isolated culture of Muscodor crispans grown on potato dextrose agar, providing said composition is absent naphthalene and azulene derivative compounds.

37. The composition of claim 36 wherein said acid component is selected from isobutyric acid, propanoic acid and combinations thereof.

38. The composition of claim 36 wherein said ester component is selected from a C 4 ester acetate, a C 5 ester acetate and combinations thereof.

39. The composition of claim 36 comprising 8-10 said components isolatable from a volatile by-product of M. crispans.

40. The composition of claim 39 wherein each said component of said composition is isolatable from a volatile by-product of M. crispans.

41. The composition of claim 36 where each said component of said composition is generally recognized as safe for human consumption under Chapter 21 of the United States Code of Federal Regulations.

42. The composition of claim 36 comprising a rhamnolipid component.

43. An antimicrobial composition comprising an acid component selected from C 2 -C 5 acids, acid salts and combinations thereof; a C 2 -C 5 acid ester component; a C 3 -C 5 ketone component; and at least two C 2 -C 5 components isolatable from a volatile by-product of an isolated culture of Muscodor crispans grown on potato dextrose agar, providing said composition is absent naphthalene and azulene derivative compounds.

44. The composition of claim 43 wherein said acid component is selected from isobutyric acid, salts of isobutyric acid and combinations thereof.

45. The composition of claim 44 wherein said acid component is selected from isobutyric acid and a potassium salt thereof.

46. The composition of claim 43 wherein said ester component is selected from esters of acetic acid, propanoic acid and isobutyric acid and combinations of said esters.

47. The composition of claim 43 comprising 8-10 said components isolatable from a volatile by-product of M. crispans.

48. The composition of claim 43 comprising a rhamnolipid component.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2010
From: GANDHI, N.R.; PALMER SKEBBA, VICTORIA; STROBEL, GARY A.
To: JENEIL BIOSURFACTANT COMPANY, LLC
Reel/Frame 024429/0593 →
Continuity (4)
Provisional Application 61214752 · Apr 27, 2009
Provisional Application 61257319 · Nov 2, 2009
Provisional Application 61315611 · Mar 19, 2010
Related Publication 20100272690A1 · Oct 28, 2010